This area of research captures the expression patterns from both the genome and proteins and uses them to differentiate between what is normal and abnormal.  There is lots of excitement in this field regarding the creation and development of new tools for improving the detection, diagnosis and treatment of cancer at the molecular level.

There will be particular focus on point-of-care diagnostics, predictive biomarkers and their discovery and detection.  Additionally, the cutting-edge subjects of circulating tumour cells and diagnostic applications of exosomes will be explored, giving delegates a brilliant insight into this rapidly expanding field.

 

 

Lita Nelsen, Director, Massachusetts Institute of Technology

Norman Nelson, Senior Consultant, NCN Enterprises

John Quackenbush, Professor of Computational Biology, Dana Farber Cancer Institute

Agenda Topics

      •   Cancer Personalised Medicine
      •   Companion Diagnostics
      •   Emerging Classes of Biomarkers for MDx
      •   Emerging technologies in MDx
      •   MDx for Infectious Diseases
      •   Next-Generation Sequencing: Its Impact on MDx
      •   Oncology Biomarkers

Poster Submission Deadline: 31 August 2013

 

 

Now, when you buy one full priced delegate pass, you can share the experience with a colleague for FREE!

This promotion expires on 31^st December 2012, so be sure to register as soon as possible to take advantage!

 

Terms and Conditions apply.  Visit website for more information, and to register.

 

Town and Country Resort Hotel
500 Hotel Circle North 
San Diego 
California 
92108

Tel: 619-291-7131

More information on accommodation rates is on the website.

 

Aaron Woodley, Exhibition Manager
a.woodley@selectbio.com
+44 (0)1787 315129

 

+44 (0) 1787 315110